An Interventional Study of Milk Allergy
The Impact of the Diet Containing Limited Amounts of Processed Milk Protein on the Natural History of IgE-Mediated Milk Hypersensitivity
2 other identifiers
interventional
220
1 country
1
Brief Summary
Milk is the among the most common food allergens in infants and children. The majority of children outgrow their allergies; however, the exact mechanisms by which food tolerance is achieved are unknown. Strict avoidance of the offending food is currently the only known therapy. However, subjects have been known to lose food hypersensitivity while frequently ingesting small amounts of processed forms of the offending product. The purpose of this study is to investigate whether ingestion of small amounts of processed milk protein will be permitted without compromising the chances of either outgrowing milk hypersensitivity or prolonging the time needed to achieve clinical tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Jun 2004
Longer than P75 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 19, 2007
CompletedFirst Posted
Study publicly available on registry
December 21, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedAugust 1, 2012
July 1, 2012
6.7 years
December 19, 2007
July 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tolerance to heated milk
Throughout study
Secondary Outcomes (1)
Development of tolerance to non-heated milk
Throughout study
Study Arms (1)
1
EXPERIMENTALBaked milk and at least 4 oral food challenges as clinically indicated
Interventions
Eligibility Criteria
You may qualify if:
- Positive prick skin test to milk and/or detectable serum milk-IgE
- History of allergic reaction to milk within past 6 months
- Serum milk-IgE of high predictive value (\>15 in children older than 1 year, \>5 in children younger than 1 year)
- Asymptomatic or stabilized atopic disease (asthma, allergic rhinitis, atopic dermatitis) for a minimum of 7 days prior to OFC
You may not qualify if:
- Serum level of cow's milk-specific IgE antibody greater than 35 kIU/L
- History of anaphylactic reaction to cow's milk within the past 12 months
- Unstable asthma
- Allergic eosinophilic gastroenteritis caused by milk
- Use of short-acting antihistamines more than one time within 3 days of OFC
- Use of medium-acting antihistamines more than one time within 7 days of OFC
- Maintenance therapy or use of beta-blockers and ACE inhibitors within 12 to 24 hours of OFC
- Participation in study baked egg study GCO#03-0609 within 6 months of enrollment
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai School of Medicine
New York, New York, United States
Related Publications (3)
Skripak JM, Matsui EC, Mudd K, Wood RA. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol. 2007 Nov;120(5):1172-7. doi: 10.1016/j.jaci.2007.08.023. Epub 2007 Nov 1.
PMID: 17935766BACKGROUNDStaden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy. 2007 Nov;62(11):1261-9. doi: 10.1111/j.1398-9995.2007.01501.x.
PMID: 17919140BACKGROUNDVandenplas Y, Koletzko S, Isolauri E, Hill D, Oranje AP, Brueton M, Staiano A, Dupont C. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child. 2007 Oct;92(10):902-8. doi: 10.1136/adc.2006.110999.
PMID: 17895338BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hugh A. Sampson, MD
- PRINCIPAL INVESTIGATOR
Scott H. Sicherer, MD
- PRINCIPAL INVESTIGATOR
Anna Nowak-Wegrzyn, MD
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2007
First Posted
December 21, 2007
Study Start
June 1, 2004
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
August 1, 2012
Record last verified: 2012-07